Pharmaxis Announces Delay to French Pricing for Bronchitol

29th Aug 13

Release Date: 29/08/2013 12:00am

Pharmaceutical company Pharmaxis (ASX:PXS) today announced it will scale back resources and investments dedicated to the launch of Bronchitol in France due to delays in reaching an agreement with French authorities on a reimbursed price for  the cystic fibrosis treatment.

Read full media release - pdf

Categories: News and Media